USPTO serial 79117398
E ERYTECH PHARMA
Reviewed by CopyMark Law Group
Reg. 4398244Status 404
- Filing date
- Status date
- Registration date
- Sep 10, 2013
- Examiner
- MITTLER, ROBIN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with E ERYTECH PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
F-69008 LYON, FR
F-69008 LYON, FR
F-69008 LYON, FR
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of cancer, blood diseases and disorders, metabolic disorders, genetic rare diseases and immunological condition ; Diagnostic preparations for medical purposes, veterinary preparations for treatment of cancer and blood diseases and disorders, metabolic disorders, genetic rare diseases and immunological condition in horses, cattle, dogs and cats; chemical preparations for medical or pharmaceutical use, namely, for the prevention and treatment of cancer, blood diseases and disorders, metabolic disorders, genetic rare diseases and immunological condition | SECTION 71 - CANCELLED | — |
| 042 | Evaluations, estimates and research in the scientific and technological fields provided by engineers, namely, materials testing and evaluation, pharmaceutical product evaluation, scientific research, and technology research in the field of scientific equipment for developing pharmaceuticals and encapsulation in erythrocyte; research and development of new products for others | SECTION 71 - CANCELLED | — |
| 044 | Medical services; hospitals | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ERYTECH Pharma
- Other trademarks owned by ERYTECH Pharma
- Other trademarks owned by ERYTECH Pharma
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named E ERYTECH PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 14, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jan 14, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jan 29, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 29, 2021 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 29, 2021 | INPC | INVALIDATION PROCESSED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Apr 27, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 20, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 19, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 25, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 11, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 11, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 10, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 10, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 21, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 25, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 19, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 19, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 5, 2013 | NPUB | NOTICE OF PUBLICATION | — |
| May 22, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 21, 2013 | ALIE | ASSIGNED TO LIE | — |
| May 20, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 18, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 18, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2013 | ALIE | ASSIGNED TO LIE | — |
| Apr 17, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 5, 2012 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 18, 2012 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 18, 2012 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 18, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 17, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 2, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 28, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 27, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |